Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 April - 4 May 2024 and includes updates on cholera, MERS-CoV, SARS-CoV-2, an overview of respiratory virus epidemiology in the EU/EEA, highly pathogenic avian influenza A(H5N1) in cattle and a related human case, Crimean-Congo haemorrhagic fever, and Lassa fever.
Campylobacteriosis is the most frequently reported food- and waterborne disease in the EU/EEA. In 2018, 30 EU/EEA countries reported 250 384 confirmed cases of campylobacteriosis.
For 2020, 29 EU/EEA countries reported 123 062 confirmed cases of campylobacteriosis. This represents a reduction of 26.0% compared with 2019 (UK cases excluded).
This report provides a record of the impact noted by countries on HIV services and monitoring capacity which can be used retrospectively to better understand the effects of the COVID-19 pandemic on the HIV situation in the European Region.
In a bid to enhance collaboration and share best practices in HIV prevention and control, representatives from the European Centre for Disease Prevention and Control (ECDC), Cyprus, and Egypt convened in Cairo for the first Exchange of Experts meeting in 2024.